Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The rapid scale up of opioid substitution treatment (OST) for drug users mainly achieved through the possibility of prescribing buprenorphine in primary care has been successful in reducing HIV prevalence among drug users but still inadequate for reducing the spread of HCV. To date, methadone in France can only be initialised in drug centres but GPs can prescribe methadone after stabilisation of dosages.

This study was born as an answer to a request from the French Minister of Health that supports the initialisation of methadone in primary care in order to improve coverage by OST (now 70%) in drug users.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
• Treatments: Methadone

Criteria

Inclusion Criteria:

• 18 to 70 years patients needing methadone for their opioid dependence who are either naives of methadone treatment (prescribed) since at least 1 month

• need to switch from buprenorphine to methadone treatment

• negative test for pregnancy

Exclusion Criteria:

• co-dependent on alcohol and benzodiazepines,

• inmates,

• pregnant women,

• individual in irregular situation or who cannot be joined by phone.